Benchmarking
Market ComparisonApr 2026
Florida's two-year sales growth of 9.4% outpaces what its modest 2.5% annual figure suggests, pointing to a market that gained meaningful momentum before settling into a steadier pace. With 744 dispensaries and store count growth of just 2.1%, expansion is measured compared to adult-use states, but per-location performance remains a draw for operators in a medical-only environment with limited license availability.
24-Month Trend

| State | Sales | YoY |
|---|---|---|
| California | $340-350M | 1.3% |
| Michigan | $250-260M | 4.6% |
| Florida | $170-180M | 1.3% |
| New York | $150-160M | 6.7% |
| Massachusetts | $150-160M | 0.8% |
Benchmarking
Market ComparisonApr 2026
Florida's two-year sales growth of 9.4% outpaces what its modest 2.5% annual figure suggests, pointing to a market that gained meaningful momentum before settling into a steadier pace. With 744 dispensaries and store count growth of just 2.1%, expansion is measured compared to adult-use states, but per-location performance remains a draw for operators in a medical-only environment with limited license availability.
24-Month Trend

| State | Sales | YoY |
|---|---|---|
| California | $340-350M | +1.3% |
| Michigan | $250-260M | -4.6% |
| Florida | $170-180M | +1.3% |
| New York | $150-160M | +6.7% |
| Massachusetts | $150-160M | +0.8% |